Page last updated: 2024-11-01

omeprazole and Arterial Diseases, Carotid

omeprazole has been researched along with Arterial Diseases, Carotid in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, Y1
Tao, Z1
Song, C1
Jia, Q1
Bai, J1
Zhi, K1
Qu, L1

Other Studies

1 other study available for omeprazole and Arterial Diseases, Carotid

ArticleYear
Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Adipokines; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Protei

2013